250 related articles for article (PubMed ID: 30175975)
1. Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway.
Wang S; He B; Hang W; Wu N; Xia L; Wang X; Zhang Q; Zhou X; Feng Z; Chen Q; Chen J
J Alzheimers Dis; 2018; 65(4):1385-1400. PubMed ID: 30175975
[TBL] [Abstract][Full Text] [Related]
2. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes.
Yang Y; Ma D; Wang Y; Jiang T; Hu S; Zhang M; Yu X; Gong CX
J Alzheimers Dis; 2013; 33(2):329-38. PubMed ID: 22936005
[TBL] [Abstract][Full Text] [Related]
3. Berberine ameliorates neuronal AD-like change via activating Pi3k/PGCε pathway.
Wu N; Liu W; Wang J; Han Y; Ye Y; Liu X; Yu Y; Chen Q; Bao Y; Liu C
Biofactors; 2021 Jul; 47(4):587-599. PubMed ID: 33740285
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model.
Moghazy HM; Abdelhaliem NG; Mohammed SA; Hassan A; Abdelrahman A
Pflugers Arch; 2024 May; 476(5):779-795. PubMed ID: 38536493
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/β-catenin/NeuroD1 pathway.
Kang X; Wang D; Zhang L; Huang T; Liu S; Feng X; Guo Y; Zhang Z; Wang Z; Ren H; Yuan G
Mol Med; 2023 Sep; 29(1):118. PubMed ID: 37667187
[TBL] [Abstract][Full Text] [Related]
6. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells.
Chang W; Zhang M; Meng Z; Yu Y; Yao F; Hatch GM; Chen L
Eur J Pharmacol; 2015 Dec; 769():55-63. PubMed ID: 26522928
[TBL] [Abstract][Full Text] [Related]
7. Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3-kinase-protein kinase B pathway in diabetic rats.
Ni WJ; Zhou H; Ding HH; Tang LQ
J Diabetes Investig; 2020 Mar; 11(2):297-306. PubMed ID: 31336024
[TBL] [Abstract][Full Text] [Related]
8. Effects of Berberine on Diabetes and Cognitive Impairment in an Animal Model: The Mechanisms of Action.
Zhang JH; Zhang JF; Song J; Bai Y; Deng L; Feng CP; Xu XY; Guo HX; Wang Y; Gao X; Gu Y; Jin C; Zheng JF; Zhen Z; Su H
Am J Chin Med; 2021; 49(6):1399-1415. PubMed ID: 34137676
[TBL] [Abstract][Full Text] [Related]
9. Axonal and dendritic changes are associated with diabetic encephalopathy in rats: an important risk factor for Alzheimer's disease.
Zhou Y; Luo Y; Dai J
J Alzheimers Dis; 2013; 34(4):937-47. PubMed ID: 23302655
[TBL] [Abstract][Full Text] [Related]
10. Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats.
Xu W; Liu J; Ma D; Yuan G; Lu Y; Yang Y
PLoS One; 2017; 12(2):e0172477. PubMed ID: 28225806
[TBL] [Abstract][Full Text] [Related]
11. Trans-resveratrol Inhibits Tau Phosphorylation in the Brains of Control and Cadmium Chloride-Treated Rats by Activating PP2A and PI3K/Akt Induced-Inhibition of GSK3β.
Shati AA; Alfaifi MY
Neurochem Res; 2019 Feb; 44(2):357-373. PubMed ID: 30478674
[TBL] [Abstract][Full Text] [Related]
12. Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy.
Qiu YY; Tang LQ; Wei W
Mol Cell Endocrinol; 2017 Mar; 443():89-105. PubMed ID: 28087385
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
14. Ferulic acid attenuates diabetes-induced cognitive impairment in rats via regulation of PTP1B and insulin signaling pathway.
Wang H; Sun X; Zhang N; Ji Z; Ma Z; Fu Q; Qu R; Ma S
Physiol Behav; 2017 Dec; 182():93-100. PubMed ID: 28988132
[TBL] [Abstract][Full Text] [Related]
15. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S
J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064
[TBL] [Abstract][Full Text] [Related]
16. Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance.
Chen Y; Chen Y; Liang Y; Chen H; Ji X; Huang M
Biomed Pharmacother; 2020 Jan; 121():109670. PubMed ID: 31810131
[TBL] [Abstract][Full Text] [Related]
17. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
Ali T; Kim MO
J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
[TBL] [Abstract][Full Text] [Related]
18. Berberine attenuates axonal transport impairment and axonopathy induced by Calyculin A in N2a cells.
Liu X; Zhou J; Abid MD; Yan H; Huang H; Wan L; Feng Z; Chen J
PLoS One; 2014; 9(4):e93974. PubMed ID: 24713870
[TBL] [Abstract][Full Text] [Related]
19. Seipin deletion in mice enhances phosphorylation and aggregation of tau protein through reduced neuronal PPARγ and insulin resistance.
Chang H; Di T; Wang Y; Zeng X; Li G; Wan Q; Yu W; Chen L
Neurobiol Dis; 2019 Jul; 127():350-361. PubMed ID: 30910747
[TBL] [Abstract][Full Text] [Related]
20. Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway.
Gandhi GR; Jothi G; Antony PJ; Balakrishna K; Paulraj MG; Ignacimuthu S; Stalin A; Al-Dhabi NA
Eur J Pharmacol; 2014 Dec; 745():201-16. PubMed ID: 25445038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
